UA73531C2 - Disinfection composition of thixotropic hydrogel - Google Patents
Disinfection composition of thixotropic hydrogel Download PDFInfo
- Publication number
- UA73531C2 UA73531C2 UA2002054035A UA2002054035A UA73531C2 UA 73531 C2 UA73531 C2 UA 73531C2 UA 2002054035 A UA2002054035 A UA 2002054035A UA 2002054035 A UA2002054035 A UA 2002054035A UA 73531 C2 UA73531 C2 UA 73531C2
- Authority
- UA
- Ukraine
- Prior art keywords
- composition according
- electrolytic
- electrolyte
- composition
- viscosity
- Prior art date
Links
- 230000009974 thixotropic effect Effects 0.000 title claims abstract description 18
- 239000000017 hydrogel Substances 0.000 title claims abstract description 11
- 239000000203 mixture Substances 0.000 title claims description 50
- 238000004659 sterilization and disinfection Methods 0.000 title description 5
- 239000000126 substance Substances 0.000 claims description 26
- 239000000460 chlorine Substances 0.000 claims description 25
- 229910052801 chlorine Inorganic materials 0.000 claims description 25
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 24
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 24
- 239000000645 desinfectant Substances 0.000 claims description 20
- 239000003795 chemical substances by application Substances 0.000 claims description 19
- 239000003792 electrolyte Substances 0.000 claims description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 17
- WQYVRQLZKVEZGA-UHFFFAOYSA-N hypochlorite Chemical compound Cl[O-] WQYVRQLZKVEZGA-UHFFFAOYSA-N 0.000 claims description 12
- QWPPOHNGKGFGJK-UHFFFAOYSA-N hypochlorous acid Chemical compound ClO QWPPOHNGKGFGJK-UHFFFAOYSA-N 0.000 claims description 12
- 239000011780 sodium chloride Substances 0.000 claims description 12
- 239000004927 clay Substances 0.000 claims description 11
- 230000015572 biosynthetic process Effects 0.000 claims description 6
- 239000003607 modifier Substances 0.000 claims description 6
- 230000007423 decrease Effects 0.000 claims description 3
- 238000005868 electrolysis reaction Methods 0.000 claims description 3
- 230000036961 partial effect Effects 0.000 claims description 3
- 238000012876 topography Methods 0.000 claims 1
- 239000005708 Sodium hypochlorite Substances 0.000 abstract description 5
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 abstract description 5
- 239000004599 antimicrobial Substances 0.000 abstract description 4
- 231100000065 noncytotoxic Toxicity 0.000 abstract description 3
- 230000002020 noncytotoxic effect Effects 0.000 abstract description 3
- 230000000699 topical effect Effects 0.000 abstract description 3
- 239000000499 gel Substances 0.000 description 25
- 206010052428 Wound Diseases 0.000 description 20
- 208000027418 Wounds and injury Diseases 0.000 description 19
- 238000000034 method Methods 0.000 description 16
- 239000000243 solution Substances 0.000 description 16
- 208000015181 infectious disease Diseases 0.000 description 13
- 210000003491 skin Anatomy 0.000 description 13
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 12
- 230000000845 anti-microbial effect Effects 0.000 description 9
- 239000007788 liquid Substances 0.000 description 9
- 244000005700 microbiome Species 0.000 description 9
- 230000002421 anti-septic effect Effects 0.000 description 7
- 239000002734 clay mineral Substances 0.000 description 6
- 241000894006 Bacteria Species 0.000 description 5
- 239000000758 substrate Substances 0.000 description 5
- 241000233866 Fungi Species 0.000 description 4
- 239000008367 deionised water Substances 0.000 description 4
- 229910021641 deionized water Inorganic materials 0.000 description 4
- KWLMIXQRALPRBC-UHFFFAOYSA-L hectorite Chemical compound [Li+].[OH-].[OH-].[Na+].[Mg+2].O1[Si]2([O-])O[Si]1([O-])O[Si]([O-])(O1)O[Si]1([O-])O2 KWLMIXQRALPRBC-UHFFFAOYSA-L 0.000 description 4
- 229910000271 hectorite Inorganic materials 0.000 description 4
- 229910052500 inorganic mineral Inorganic materials 0.000 description 4
- 229940094522 laponite Drugs 0.000 description 4
- XCOBTUNSZUJCDH-UHFFFAOYSA-B lithium magnesium sodium silicate Chemical compound [Li+].[Li+].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[Na+].[Na+].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3 XCOBTUNSZUJCDH-UHFFFAOYSA-B 0.000 description 4
- 235000010755 mineral Nutrition 0.000 description 4
- 239000011707 mineral Substances 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 239000007800 oxidant agent Substances 0.000 description 4
- 230000001717 pathogenic effect Effects 0.000 description 4
- 235000011121 sodium hydroxide Nutrition 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 229940064004 antiseptic throat preparations Drugs 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 239000003623 enhancer Substances 0.000 description 3
- 239000012467 final product Substances 0.000 description 3
- 150000002500 ions Chemical class 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 239000010453 quartz Substances 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- 208000035143 Bacterial infection Diseases 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 208000022362 bacterial infectious disease Diseases 0.000 description 2
- 238000004061 bleaching Methods 0.000 description 2
- 239000007844 bleaching agent Substances 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 230000001472 cytotoxic effect Effects 0.000 description 2
- 230000002458 infectious effect Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 150000008040 ionic compounds Chemical class 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 239000000693 micelle Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052625 palygorskite Inorganic materials 0.000 description 2
- 230000035515 penetration Effects 0.000 description 2
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 238000011012 sanitization Methods 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 230000029663 wound healing Effects 0.000 description 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 206010007882 Cellulitis Diseases 0.000 description 1
- 208000018380 Chemical injury Diseases 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 206010011409 Cross infection Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- 206010017533 Fungal infection Diseases 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 206010021531 Impetigo Diseases 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- RJQXTJLFIWVMTO-TYNCELHUSA-N Methicillin Chemical compound COC1=CC=CC(OC)=C1C(=O)N[C@@H]1C(=O)N2[C@@H](C(O)=O)C(C)(C)S[C@@H]21 RJQXTJLFIWVMTO-TYNCELHUSA-N 0.000 description 1
- 208000031888 Mycoses Diseases 0.000 description 1
- 206010029803 Nosocomial infection Diseases 0.000 description 1
- 206010057249 Phagocytosis Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 239000004113 Sepiolite Substances 0.000 description 1
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 206010046543 Urinary incontinence Diseases 0.000 description 1
- 238000005411 Van der Waals force Methods 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010048038 Wound infection Diseases 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 150000001342 alkaline earth metals Chemical class 0.000 description 1
- 150000004996 alkyl benzenes Chemical class 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000002924 anti-infective effect Effects 0.000 description 1
- 229960000892 attapulgite Drugs 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 229940077388 benzenesulfonate Drugs 0.000 description 1
- 229920001222 biopolymer Polymers 0.000 description 1
- 230000005587 bubbling Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 229960001631 carbomer Drugs 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- -1 chlorine ions Chemical class 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 231100000433 cytotoxic Toxicity 0.000 description 1
- 231100000599 cytotoxic agent Toxicity 0.000 description 1
- 239000002619 cytotoxin Substances 0.000 description 1
- 230000008260 defense mechanism Effects 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 230000000249 desinfective effect Effects 0.000 description 1
- GUJOJGAPFQRJSV-UHFFFAOYSA-N dialuminum;dioxosilane;oxygen(2-);hydrate Chemical compound O.[O-2].[O-2].[O-2].[Al+3].[Al+3].O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O GUJOJGAPFQRJSV-UHFFFAOYSA-N 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 229950003499 fibrin Drugs 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 159000000011 group IA salts Chemical class 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 150000004679 hydroxides Chemical class 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 229910052622 kaolinite Inorganic materials 0.000 description 1
- CYPPCCJJKNISFK-UHFFFAOYSA-J kaolinite Chemical compound [OH-].[OH-].[OH-].[OH-].[Al+3].[Al+3].[O-][Si](=O)O[Si]([O-])=O CYPPCCJJKNISFK-UHFFFAOYSA-J 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 229960003085 meticillin Drugs 0.000 description 1
- 244000005706 microflora Species 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 229910052901 montmorillonite Inorganic materials 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 230000037125 natural defense Effects 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 229910000273 nontronite Inorganic materials 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 1
- 239000006174 pH buffer Substances 0.000 description 1
- 230000008782 phagocytosis Effects 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 229910000275 saponite Inorganic materials 0.000 description 1
- 229910000276 sauconite Inorganic materials 0.000 description 1
- 229910052624 sepiolite Inorganic materials 0.000 description 1
- 235000019355 sepiolite Nutrition 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 238000007711 solidification Methods 0.000 description 1
- 230000008023 solidification Effects 0.000 description 1
- 239000012086 standard solution Substances 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 239000003206 sterilizing agent Substances 0.000 description 1
- WGPCGCOKHWGKJJ-UHFFFAOYSA-N sulfanylidenezinc Chemical compound [Zn]=S WGPCGCOKHWGKJJ-UHFFFAOYSA-N 0.000 description 1
- 238000011477 surgical intervention Methods 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000002522 swelling effect Effects 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical class [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 229910052902 vermiculite Inorganic materials 0.000 description 1
- 239000010455 vermiculite Substances 0.000 description 1
- 235000019354 vermiculite Nutrition 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 229910052984 zinc sulfide Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N59/00—Biocides, pest repellants or attractants, or plant growth regulators containing elements or inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/20—Elemental chlorine; Inorganic compounds releasing chlorine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Agronomy & Crop Science (AREA)
- Environmental Sciences (AREA)
- Pest Control & Pesticides (AREA)
- Plant Pathology (AREA)
- Dentistry (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Cosmetics (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/422,327 US6333054B1 (en) | 1999-10-21 | 1999-10-21 | Topical, non-cytotoxic, antimicrobial hydrogel with thixotropic properties |
| PCT/US2000/041341 WO2001028336A1 (en) | 1999-10-21 | 2000-10-20 | A topical, non-cytotoxic, antimicrobial hydrogel with thixotropic properties |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA73531C2 true UA73531C2 (en) | 2005-08-15 |
Family
ID=23674394
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UA2002054035A UA73531C2 (en) | 1999-10-21 | 2000-10-20 | Disinfection composition of thixotropic hydrogel |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US6333054B1 (zh) |
| EP (1) | EP1259114B1 (zh) |
| JP (1) | JP5546086B2 (zh) |
| KR (1) | KR20020075364A (zh) |
| CN (1) | CN1195415C (zh) |
| AT (1) | ATE285681T1 (zh) |
| AU (1) | AU771117B2 (zh) |
| BG (1) | BG106709A (zh) |
| CA (1) | CA2388809C (zh) |
| CZ (1) | CZ301637B6 (zh) |
| DE (1) | DE60017196T2 (zh) |
| EA (1) | EA005568B1 (zh) |
| ES (1) | ES2234705T3 (zh) |
| GE (1) | GEP20043399B (zh) |
| HK (1) | HK1049764B (zh) |
| HU (1) | HU229274B1 (zh) |
| IL (2) | IL149214A0 (zh) |
| MX (1) | MXPA02003893A (zh) |
| PL (1) | PL200322B1 (zh) |
| PT (1) | PT1259114E (zh) |
| SK (1) | SK285822B6 (zh) |
| UA (1) | UA73531C2 (zh) |
| WO (1) | WO2001028336A1 (zh) |
Families Citing this family (59)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2355190B (en) * | 1999-08-23 | 2004-07-28 | Sterilox Medical | Improvements in or relating to sterilising preparations |
| US7393522B2 (en) * | 2000-01-12 | 2008-07-01 | Novabay Pharmaceuticals, Inc. | Physiologically balanced, ionized, acidic solution and methodology for use in wound healing |
| JP5140218B2 (ja) | 2001-09-14 | 2013-02-06 | 有限会社コヒーレントテクノロジー | 表面洗浄・表面処理に適した帯電アノード水の製造用電解槽及びその製造法、並びに使用方法 |
| ES2377945T3 (es) | 2001-12-05 | 2012-04-03 | Oculus Innovative Sciences, Inc. | Método y aparato para producir agua con potencial de oxidación y reducción (ORP) negativo y positivo |
| PT1474109E (pt) * | 2001-12-21 | 2010-10-25 | Alcon Inc | Utilização de nanopartículas inorgânicas sintéticas como veículos em medicamentos oftálmicos |
| US7435380B2 (en) * | 2002-09-30 | 2008-10-14 | Church & Dwight Co., Inc. | Pseudo-plastic or thixotropic liquid deodorant product for ostomy pouches |
| US9168318B2 (en) | 2003-12-30 | 2015-10-27 | Oculus Innovative Sciences, Inc. | Oxidative reductive potential water solution and methods of using the same |
| KR20050086324A (ko) * | 2004-02-25 | 2005-08-30 | 김아란 | 3%부터 9%까지 셀라인 (염수) |
| US20050266081A1 (en) * | 2004-05-26 | 2005-12-01 | Rogozinski Wallace J | Antimicrobial silver hydrogels |
| US20050271609A1 (en) * | 2004-06-08 | 2005-12-08 | Colgate-Palmolive Company | Water-based gelling agent spray-gel and its application in personal care formulation |
| BRPI0609711B8 (pt) | 2005-03-23 | 2021-05-25 | Oculus Innovative Sciences Inc | uso de uma solução aquosa com potencial redutivo oxidativo (orp) |
| US20060241002A1 (en) * | 2005-04-26 | 2006-10-26 | Rogozinski Wallace J | Sodium hypochlorite gel composition |
| WO2006119300A2 (en) | 2005-05-02 | 2006-11-09 | Oculus Innovative Sciences, Inc. | Method of using oxidative reductive potential water solution in dental applications |
| WO2007070637A2 (en) * | 2005-12-13 | 2007-06-21 | Puricore, Inc. | Method of treating open wounds using hypochlorous acid |
| US8147444B2 (en) | 2006-01-20 | 2012-04-03 | Oculus Innovative Sciences, Inc. | Methods of treating or preventing peritonitis with oxidative reductive potential water solution |
| US7846888B2 (en) * | 2006-02-07 | 2010-12-07 | Battelle Energy Alliance, Llc | Long lasting decontamination foam |
| US7915472B2 (en) * | 2006-02-07 | 2011-03-29 | Battelle Energy Alliance, Llc | Surface decontamination compositions and methods |
| WO2007094413A1 (ja) * | 2006-02-16 | 2007-08-23 | Toyo University | 経皮投与用医薬組成物 |
| US20090169646A1 (en) * | 2006-02-22 | 2009-07-02 | Puricore, Inc. | Methods of treating cystic fibrosis |
| US20070243264A1 (en) * | 2006-04-18 | 2007-10-18 | Aram Garabedian | Thickened Dilute Hypochlorite |
| US20070292488A1 (en) * | 2006-06-14 | 2007-12-20 | Mansour Bassiri | Method for treatment of wound treatment using aganocides |
| US9999635B2 (en) | 2007-01-16 | 2018-06-19 | Realm Therapeutics, Inc. | Methods and compositions for treating inflammatory disorders |
| DE102007022994A1 (de) * | 2007-05-15 | 2008-11-20 | Actides Gmbh | Desinfektionsmittel auf der Basis elektrochemisch aktivierter Wasser-/Elektrolytlösungen, Verfahren zu deren Herstellung sowie Verwendung derselben |
| JP5369307B2 (ja) * | 2007-12-28 | 2013-12-18 | アース製薬株式会社 | ゲル状害虫用スプレー製品 |
| WO2010148004A1 (en) | 2009-06-15 | 2010-12-23 | Oculus Innovative Sciences, Inc. | Solution containing hypochlorous acid and methods of using same |
| US11452778B2 (en) | 2011-03-18 | 2022-09-27 | Urgo Us, Inc. | Stabilized hypohalous acid solutions |
| WO2012129161A2 (en) | 2011-03-18 | 2012-09-27 | Puricore, Inc. | Stabilized hypohalous acid solutions |
| US9381214B2 (en) | 2011-03-18 | 2016-07-05 | Puricore, Inc. | Methods for treating skin irritation |
| EP2543359A1 (de) * | 2011-07-08 | 2013-01-09 | Caliopa AG | Gel zur Verwendung in einem Wundbehandlungsmittel |
| DE102011055182A1 (de) * | 2011-11-09 | 2013-05-16 | Monopharm Beratungs- Und Handelsgesellschaft Mbh | Anolyt, Verfahren zu dessen Herstellung und dessen Verwendung |
| US11672825B2 (en) | 2012-02-17 | 2023-06-13 | Wiab Water Innovation Ab | Acetic acid and hypochlorous acid compositions for treatment of biofilms and wound care |
| US11452741B2 (en) | 2012-02-17 | 2022-09-27 | Wiab Water Innovation Ab | Compositions and methods for treating transient biofilms |
| US11357794B2 (en) | 2012-02-17 | 2022-06-14 | Wiab Wafer Innovation Ab | Preparations for controlled-release of hypochlorous acid |
| US11364262B2 (en) | 2012-02-17 | 2022-06-21 | Wiab Water Innovation Ab | Acetic acid and hypochlorous acid compositions for treatment of skin trauma |
| US11484549B2 (en) | 2012-02-17 | 2022-11-01 | Wiab Water Innovation Ab | Compositions and methods for treating biofilms without inducing antimicrobial resistance |
| US10675299B2 (en) | 2012-02-17 | 2020-06-09 | Wiab Water Innovation Ab | Hand disinfectant |
| US11364263B2 (en) | 2012-02-17 | 2022-06-21 | Wiab Wafer Innovation Ab | Compositions and methods for aerodigestive treatment |
| EP3388389B1 (en) | 2012-02-17 | 2023-09-06 | Wiab Water Innovation AB | Compositions of hypochlorous acid (hoci) and methods of manufacture thereof |
| US11478507B2 (en) | 2012-02-17 | 2022-10-25 | Wiab Water Innovation Ab | Compositions and methods for treating biofilms |
| US9499772B2 (en) | 2013-03-13 | 2016-11-22 | Battelle Energy Alliance, Llc | Methods of decontaminating surfaces and related compositions |
| US9757387B2 (en) | 2013-05-02 | 2017-09-12 | Medical Technology Research Inc | Antimicrobial compositions and methods of making the same |
| CN103341215B (zh) * | 2013-06-04 | 2016-03-02 | 青岛中腾生物技术有限公司 | 一种抗菌防粘连材料及其制备方法 |
| US20150099010A1 (en) | 2013-10-07 | 2015-04-09 | Reoxcyn Discoveries Group, Inc | Redox signaling gel formulation |
| US10617716B2 (en) * | 2014-12-16 | 2020-04-14 | Urgo Us, Inc. | Hypochlorous acid formulations and methods for treating skin conditions |
| EP3233091A4 (en) | 2014-12-16 | 2018-07-18 | Realm Therapeutics, Inc. | Hypochlorous acid formulations and methods for treating skin conditions |
| JP6646355B2 (ja) * | 2015-01-22 | 2020-02-14 | 株式会社双葉マテリアル | チクソ性組成物 |
| US10485827B2 (en) | 2016-01-19 | 2019-11-26 | Rdg Holdings, Inc. | Topical eye serum compositions, methods or preparing, and methods of use |
| RU2657776C2 (ru) * | 2016-05-16 | 2018-06-15 | Алексей Григорьевич Гаас | Гель для обработки и заживления ран |
| US11857674B2 (en) | 2016-05-18 | 2024-01-02 | Reoxcyn, Llc | Lubricant formulations |
| US9474768B1 (en) | 2016-05-18 | 2016-10-25 | Reoxcyn Discoveries Group, Inc. | Lubricant formulations |
| EP3463269B1 (en) * | 2016-05-27 | 2021-08-04 | Wiab Water Innovation AB | Hand disinfectant |
| CN106311171B (zh) * | 2016-08-31 | 2019-02-05 | 武汉理工大学 | 基于主客体作用实现的由溶胶转变而成的凝胶及其制备方法 |
| WO2018053273A1 (en) | 2016-09-15 | 2018-03-22 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Shear-thinning therapeutic composition, and related methods |
| JP7211951B2 (ja) * | 2016-12-22 | 2023-01-24 | ダブリューアイエービー ウォーター イノベーション エービー | バイオフィルムを処置するための酢酸および次亜塩素酸を含む組成物および方法 |
| SG11201912534SA (en) | 2017-06-28 | 2020-01-30 | Collidion Inc | Compositions, methods and uses for cleaning, disinfecting and/or sterilizing |
| CN109418289A (zh) * | 2017-09-05 | 2019-03-05 | 上海利康消毒高科技有限公司 | 一种次氯酸钠凝胶及其制备方法 |
| KR20200123421A (ko) | 2018-01-14 | 2020-10-29 | 콜리디온, 인코포레이티드 | 세척, 소독, 멸균 및/또는 치료를 위한 조성물, 키트, 방법 및 용도 |
| JP2019178318A (ja) * | 2018-03-30 | 2019-10-17 | 国立大学法人岐阜大学 | チキソトロピー性付与剤及びそれを用いた物理ゲルの製造方法 |
| EP3860667A1 (de) * | 2018-10-05 | 2021-08-11 | Sanixtreme Gmbh & Co Kg | Gel, insbesondere zur verwendung in einem wundbehandlungsmittel |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US1813109A (en) * | 1925-12-15 | 1931-07-07 | D Henry W Banks | Antiseptic composition and method of making the same |
| US3578499A (en) | 1968-08-02 | 1971-05-11 | Grace W R & Co | Gelling composition for general purpose cleaning and sanitizing |
| BE757642A (fr) | 1970-06-23 | 1971-04-01 | Labofina Sa | Procede de reticulation de polymeres d'acrylamide |
| GB1418193A (en) * | 1973-03-14 | 1975-12-17 | Wilkinson Sword Ltd | Dispenser for hypochlorite gels |
| US4035483A (en) | 1973-05-29 | 1977-07-12 | John Bunyan | Antiseptic and non-toxic substance and a method of making the same |
| US4125478A (en) | 1976-11-26 | 1978-11-14 | The Dow Chemical Company | Air treating gel employing amide polymer gelling agent |
| US4199625A (en) | 1978-06-02 | 1980-04-22 | The Dow Chemical Company | Rendering porous structures impermeable by treatment with pH insensitive gelable compositions of amide polymers |
| US4366194A (en) | 1978-06-02 | 1982-12-28 | The Dow Chemical Co. | Rendering porous structures impermeable by treatment with pH insensitive gelable compositions of amide polymers and composition |
| US4578119A (en) | 1982-08-30 | 1986-03-25 | Marcus David L | Method for clean-up of blood spills |
| US4646730A (en) | 1986-05-23 | 1987-03-03 | Johnson & Johnson Products, Inc. | Color stabilized hydrogel dressing and process |
| DE3827561C1 (zh) | 1988-08-13 | 1989-12-28 | Lts Lohmann Therapie-Systeme Gmbh & Co Kg, 5450 Neuwied, De | |
| US4927641A (en) | 1989-05-23 | 1990-05-22 | Knight Gerald L | Veterinary liniment and method |
| US5015228A (en) | 1989-06-05 | 1991-05-14 | Eastman Kodak Company | Sterilizing dressing device and method for skin puncture |
| US5271943A (en) | 1989-10-27 | 1993-12-21 | Scott Health Care | Wound gel compositions containing sodium chloride and method of using them |
| US6207201B1 (en) * | 1993-06-03 | 2001-03-27 | Amuchina International, Inc. | Sodium hypochlorite based disinfectant and sterilizer for medical-surgical instruments |
| US5858201A (en) * | 1994-07-29 | 1999-01-12 | Toto, Ltd. | Strong acid sterilizing liquid containing hypochlorous acid at a low concentration, method and apparatus for generating same, and apparatus for generating and dispensing same |
| JPH10263053A (ja) * | 1997-03-28 | 1998-10-06 | Toto Ltd | 次亜塩素酸含有酸性水生成吐出装置 |
| JPH10314747A (ja) * | 1997-05-14 | 1998-12-02 | Purazumitsukusu:Kk | 殺菌水の製造方法 |
-
1999
- 1999-10-21 US US09/422,327 patent/US6333054B1/en not_active Expired - Fee Related
-
2000
- 2000-10-20 PL PL355393A patent/PL200322B1/pl unknown
- 2000-10-20 JP JP2001530940A patent/JP5546086B2/ja not_active Expired - Fee Related
- 2000-10-20 CN CNB008145296A patent/CN1195415C/zh not_active Expired - Fee Related
- 2000-10-20 CA CA002388809A patent/CA2388809C/en not_active Expired - Fee Related
- 2000-10-20 EA EA200200476A patent/EA005568B1/ru not_active IP Right Cessation
- 2000-10-20 ES ES00988469T patent/ES2234705T3/es not_active Expired - Lifetime
- 2000-10-20 WO PCT/US2000/041341 patent/WO2001028336A1/en not_active Application Discontinuation
- 2000-10-20 EP EP00988469A patent/EP1259114B1/en not_active Expired - Lifetime
- 2000-10-20 AU AU24675/01A patent/AU771117B2/en not_active Ceased
- 2000-10-20 IL IL14921400A patent/IL149214A0/xx active IP Right Grant
- 2000-10-20 GE GE4793A patent/GEP20043399B/en unknown
- 2000-10-20 CZ CZ20021380A patent/CZ301637B6/cs not_active IP Right Cessation
- 2000-10-20 DE DE60017196T patent/DE60017196T2/de not_active Expired - Lifetime
- 2000-10-20 AT AT00988469T patent/ATE285681T1/de active
- 2000-10-20 SK SK545-2002A patent/SK285822B6/sk not_active IP Right Cessation
- 2000-10-20 HU HU0203699A patent/HU229274B1/hu not_active IP Right Cessation
- 2000-10-20 UA UA2002054035A patent/UA73531C2/uk unknown
- 2000-10-20 PT PT00988469T patent/PT1259114E/pt unknown
- 2000-10-20 MX MXPA02003893A patent/MXPA02003893A/es active IP Right Grant
- 2000-10-20 KR KR1020027005073A patent/KR20020075364A/ko not_active Application Discontinuation
-
2002
- 2002-04-18 IL IL149214A patent/IL149214A/en not_active IP Right Cessation
- 2002-05-16 BG BG106709A patent/BG106709A/bg unknown
-
2003
- 2003-03-17 HK HK03101928.2A patent/HK1049764B/zh not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2388809A1 (en) | 2001-04-26 |
| KR20020075364A (ko) | 2002-10-04 |
| EA200200476A1 (ru) | 2003-02-27 |
| AU2467501A (en) | 2001-04-30 |
| GEP20043399B (en) | 2004-07-12 |
| HK1049764B (zh) | 2005-06-10 |
| JP5546086B2 (ja) | 2014-07-09 |
| CA2388809C (en) | 2009-07-07 |
| HU229274B1 (en) | 2013-10-28 |
| PL200322B1 (pl) | 2008-12-31 |
| PL355393A1 (en) | 2004-04-19 |
| EP1259114B1 (en) | 2004-12-29 |
| JP2003511473A (ja) | 2003-03-25 |
| CN1195415C (zh) | 2005-04-06 |
| EP1259114A1 (en) | 2002-11-27 |
| HK1049764A1 (en) | 2003-07-11 |
| DE60017196D1 (de) | 2005-02-03 |
| WO2001028336A1 (en) | 2001-04-26 |
| CN1379623A (zh) | 2002-11-13 |
| MXPA02003893A (es) | 2004-09-06 |
| EA005568B1 (ru) | 2005-04-28 |
| SK285822B6 (sk) | 2007-09-06 |
| IL149214A (en) | 2006-12-31 |
| IL149214A0 (en) | 2002-11-10 |
| AU771117B2 (en) | 2004-03-11 |
| ATE285681T1 (de) | 2005-01-15 |
| SK5452002A3 (en) | 2003-01-09 |
| DE60017196T2 (de) | 2006-01-12 |
| CZ301637B6 (cs) | 2010-05-12 |
| US6333054B1 (en) | 2001-12-25 |
| BG106709A (bg) | 2003-01-31 |
| ES2234705T3 (es) | 2005-07-01 |
| HUP0203699A2 (en) | 2003-04-28 |
| PT1259114E (pt) | 2005-05-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UA73531C2 (en) | Disinfection composition of thixotropic hydrogel | |
| CA2544383C (en) | Sodium hypochlorite gel composition | |
| JP2006505516A (ja) | 生理学的にバランスのとれたイオン化された酸性溶液、および創傷治癒における使用方法 | |
| US20110195131A1 (en) | Disinfectant cleaner | |
| AU2019280025A1 (en) | Wound treatment composition | |
| US3052604A (en) | Germicidal composition | |
| AU610464B2 (en) | Germicidal composition | |
| CN1258327C (zh) | 液体抗微生物组合物 | |
| Newman | Hypochlorous Acid as an Antiseptic in Wounds | |
| NZ719455B2 (en) | Wound treatment composition | |
| JPH1180788A (ja) | 洗浄剤 |